More than 100 separate bills regulating pharmacy benefit managers that serve as conduits for drug manufacturers have been introduced in 42 states, including Oregon, this year,
Untold numbers of employers, employees and citizens are turning to a slew of sometimes pricey new COVID-19 blood tests. But serious questions about the accuracy and usefulness of some of them.
Johnson & Johnson researchers working on a vaccine against the coronavirus are “just like the heroes in the hospitals” fighting to save patients, J&J CEO Alex Gorsky said on the “Today” show a few weeks ago.
Oregon has received a donation of an experimental drug that may aid the fight against COVID-19.
Oregon lawmakers have heard more than a dozen bills so far this session on the pharmaceutical industry, many attempting to address skyrocketing costs.
The House unanimously passed legislation Wednesday morning to better regulate pharmacy benefit managers, giving enforcement powers to the Oregon Department of Consumer & Business Services, designed to ensure the PBMs act lawfully and treat pharmacists fairly.
Pharmacists appear poised to add significant teeth to the state law regulating pharmacy benefit managers, persuading the Legislature to make the first changes to the law since it was enacted in 2013.
Rep. Rob Nosse, D-Portland, touted his aggressive and innovative approach to tackling uncontrolled pharmaceutical costs on Thursday, calling on Oregon to lead where Congress has failed and other state-based reforms have fallen short.
How many times have you received a prescription at your local pharmacy or through your health plan's mail-order service, only to be confused about how to take your new drug? Most usually come with simple directions on a label and pages of drug information and daunting interaction warnings.